Predicting age of onset in familial essential tremor: how much does age of onset run in families?

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3718305)

Published in Neuroepidemiology on January 24, 2013

Authors

Elan D Louis1, Nora Hernandez, Daniel Rabinowitz, Ruth Ottman, Lorraine N Clark

Author Affiliations

1: Unit 198, Neurological Institute, 710 West 168th Street, New York, NY 10032, USA. EDL2 @ columbia.edu

Articles cited by this

Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord (2003) 3.27

The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96

A study of hereditary essential tremor. Brain (1994) 2.37

Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N.Y. Neuroepidemiology (2009) 2.28

Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord (1998) 2.11

Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology (2007) 1.98

Genetics of essential tremor. Brain (2007) 1.89

Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol (2001) 1.55

Hunting for genes in essential tremor. Eur J Neurol (2008) 1.38

Test-retest reliability of patient information on age of onset in essential tremor. Mov Disord (2000) 1.24

How familial is familial tremor? The genetic epidemiology of essential tremor. Neurology (1996) 1.11

Familial essential tremor in 4 kindreds. Prospects for genetic mapping. Arch Neurol (1997) 1.04

Family history information on essential tremor: potential biases related to the source of the cases. Mov Disord (2001) 1.01

Age-at-interview bias in anticipation studies: computer simulations and an example with panic disorder. Psychiatr Genet (1996) 0.93

New simple tests for age-at-onset anticipation: application to panic disorder. Genet Epidemiol (2005) 0.84

Testing for familial correlation in age-at-onset. Biostatistics (2002) 0.82

Articles by these authors

De novo mutations in epileptic encephalopathies. Nature (2013) 7.42

Ethical, legal, and social dimensions of epilepsy genetics. Epilepsia (2006) 5.95

RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron (2013) 4.67

Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain (2007) 4.36

Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet (2002) 3.73

The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72

Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20

Genetic testing preferences in families containing multiple individuals with epilepsy. Epilepsia (2014) 2.15

SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01

Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol (2008) 1.81

Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A (2010) 1.73

Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet (2012) 1.72

Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol (2004) 1.67

Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet (2012) 1.63

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab (2005) 1.58

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med (2009) 1.44

Systematic regulation of spine sizes and densities in pyramidal neurons. J Neurobiol (2003) 1.39

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol (2010) 1.38

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics (2010) 1.37

Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet (2011) 1.36

A population-based study of mortality in essential tremor. Neurology (2007) 1.35

Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol (2003) 1.35

The epilepsy phenome/genome project. Clin Trials (2013) 1.32

Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am J Pathol (2009) 1.27

Case-control study of the parkin gene in early-onset Parkinson disease. Arch Neurol (2006) 1.26

Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int (2011) 1.22

Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia (2002) 1.21

Familial risk of epilepsy: a population-based study. Brain (2014) 1.19

Prevalence and features of unreported dystonia in a family study of "pure" essential tremor. Parkinsonism Relat Disord (2012) 1.14

Study designs for identification of rare disease variants in complex diseases: the utility of family-based designs. Genetics (2011) 1.14

Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J Mol Neurosci (2011) 1.13

Sources of variability in blood pressure measurement using the Dinamap PRO 100 automated oscillometric device. Am J Epidemiol (2003) 1.11

SCN1A testing for epilepsy: application in clinical practice. Epilepsia (2013) 1.10

Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry (2004) 1.10

Interexpert agreement in the identification of macular location in infants at risk for retinopathy of prematurity. Arch Ophthalmol (2010) 1.09

Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Mov Disord (2007) 1.07

Evidence for distinct genetic influences on generalized and localization-related epilepsy. Epilepsia (2003) 1.06

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol (2009) 1.05

The MAPT H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol (2012) 1.05

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc (2010) 1.04

Study of possible factors associated with age of onset in essential tremor. Mov Disord (2006) 1.03

Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders. Br J Ophthalmol (2009) 1.03

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. J Clin Exp Neuropsychol (2010) 1.03

Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couns (2013) 1.03

Sociodemographic disparities in epilepsy care: Results from the Houston/New York City health care use and outcomes study. Epilepsia (2008) 1.03

Use of anterior temporal lobectomy for epilepsy in a community-based population. Arch Neurol (2012) 1.02

What's at stake? Genetic information from the perspective of people with epilepsy and their family members. Soc Sci Med (2011) 1.00

A method for estimating penetrance from families sampled for linkage analysis. Biometrics (2006) 0.99

Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov Disord (2004) 0.99

Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest (2015) 0.99

Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation (2013) 0.99

Relation of antibiotic use to risk of myocardial infarction in the general population. Am J Cardiol (2002) 0.98

Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology (2008) 0.97

Concordance of disease form in kindreds ascertained through affected individuals. Stat Med (2002) 0.97

Body mass index and hospitalization in the elderly. J Am Geriatr Soc (2003) 0.97

Epilepsy in children with attention-deficit/hyperactivity disorder. Pediatr Neurol (2010) 0.97

Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice. Am J Physiol Lung Cell Mol Physiol (2012) 0.96

Yield of epileptiform electroencephalogram abnormalities in incident unprovoked seizures: a population-based study. Epilepsia (2014) 0.95

Does rate of progression run in essential tremor families? Slower vs. faster progressors. Parkinsonism Relat Disord (2012) 0.95

Development of a Standard Reference Material for metabolomics research. Anal Chem (2013) 0.94

Use of chromosome substitution strains to identify seizure susceptibility loci in mice. Mamm Genome (2007) 0.92

Screen for expanded FMR1 alleles in patients with essential tremor. Mov Disord (2004) 0.92

Influenza vaccination coverage and timeliness among children requiring two doses, 2004-2009. Prev Med (2012) 0.89

Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88

Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008. Am J Public Health (2013) 0.88

Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene. Am J Med Genet B Neuropsychiatr Genet (2007) 0.88

Early presynaptic changes during plasticity in cultured hippocampal neurons. EMBO J (2006) 0.87

Familial cosegregation of rare genetic variants with disease in complex disorders. Eur J Hum Genet (2012) 0.86

Causal models for investigating complex genetic disease: II. what causal models can tell us about penetrance for additive, heterogeneity, and multiplicative two-locus models. Hum Hered (2011) 0.85

Evaluation of depression risk in LGI1 mutation carriers. Epilepsia (2010) 0.85

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea. PLoS One (2013) 0.85

Phenotypic concordance in 70 families with IGE-implications for genetic studies of epilepsy. Epilepsy Res (2008) 0.83

Does gatekeeping control costs for privately insured children? Findings from the 1996 medical expenditure panel survey. Pediatrics (2003) 0.82

Psychiatrists' views of the genetic bases of mental disorders and behavioral traits and their use of genetic tests. J Nerv Ment Dis (2014) 0.81

Mapping a mouse limbic seizure susceptibility locus on chromosome 10. Epilepsia (2011) 0.81

Health expenditures for privately insured adults enrolled in managed care gatekeeping vs indemnity plans. Am J Public Health (2005) 0.81

Causal models for investigating complex disease: I. A primer. Hum Hered (2011) 0.81

The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children. Atherosclerosis (2004) 0.80

Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology (2012) 0.80

Allergy after inhalation and ingestion of cereals involve different allergens in allergic and celiac disease. Recent Pat Inflamm Allergy Drug Discov (2008) 0.80

Familial aggregation of cranial tremor in familial essential tremor. Neuroepidemiology (2013) 0.79